Last Updated: August 2, 2026

Details for New Drug Application (NDA): 018140

✉ Email this page to a colleague

NDA 018140 describes ATIVAN, which is a drug marketed by Hikma and Bausch and is included in two NDAs. It is available from three suppliers. Additional details are available on the ATIVAN profile page.

The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for 018140

Tradename:	ATIVAN
Applicant:	Hikma
Ingredient:	lorazepam
Patents:	0

Pharmacology for NDA: 018140

Medical Subject Heading (MeSH) Categories for 018140

Anti-Anxiety Agents
Anticonvulsants
Antiemetics
GABA Modulators
Hypnotics and Sedatives

Suppliers and Packaging for NDA: 018140

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ATIVAN	lorazepam	INJECTABLE;INJECTION	018140	NDA	Hikma Pharmaceuticals USA Inc.	0641-6000	0641-6000-10	10 VIAL in 1 CARTON (0641-6000-10) / 10 mL in 1 VIAL (0641-6000-01)
ATIVAN	lorazepam	INJECTABLE;INJECTION	018140	NDA	Hikma Pharmaceuticals USA Inc.	0641-6001	0641-6001-25	25 VIAL in 1 CARTON (0641-6001-25) / 1 mL in 1 VIAL (0641-6001-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	2MG/ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	4MG/ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Expired US Patents for NDA 018140

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-001	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-002	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.